Subscribe To
Additional detailed analyses from phase 2 study 201 of lecanemab published as three papers in peer-reviewed journals
TOKYO and CAMBRIDGE, Mass., March 30, 2023 (GLOBE NEWSWIRE) — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (...
March 30, 2023, 11:30 pm
Sutro biopharma reports full year 2022 financial results, business highlights and select anticipated milestones
– Sutro plans to initiate a phase 2/3 registration-directed study of luvelta for patients with platin...
March 30, 2023, 8:30 pm
Why shares of viking therapeutics skyrocketed this week
Viking Therapeutics is seeing promise in an obesity drug. The company said it plans another phase 1 tri...
March 30, 2023, 2:06 pm
Annovis and buntanetap: asymmetric risk/reward ahead of parkinson's data readout
Lead asset buntanetap represents a differentiated, potentially disease-modifying mechanism of action in neurodegenerative diseases. Interim ...
March 30, 2023, 12:00 pm
Avidity's stock falls after sharing additional data about partial clinical hold
Shares of Avidity Biosciences Inc. RNA, +0.55% fell about 3.0% in premarket trading on Thursday after the company said a partial clinical hold on its ...
March 30, 2023, 7:52 am
Valneva q4: resilient pipeline and partnership with pfizer, reinforcing a promising future
Valneva's pipeline and high-stakes clinical catalysts warrant a buy rating, despite the setback in its Lyme disease ...
March 29, 2023, 10:56 pm
Warner music group to cut around 4% of its overall workforce
Warner Music Group Corp. WMG on Wednesday said it planned to cut about 270 jobs, or around 4% of its overall workforce, with most of them to be comple...
March 29, 2023, 5:44 pm
Bioxytran's positive phase 2 trial results featured in ‘vaccines' peer-reviewed journal
Bioxytran said positive top-line safety and efficacy results from the company's randomized, placebo-controlled ...
March 29, 2023, 4:04 pm
Intra-cellular (itci) depression drug meets study goal, stock up
Intra-Cellular Therapeutics (ITCI) announces positive top-line data from its phase III study evaluating...
March 29, 2023, 1:46 pm
Kulr technology says appointment of ex goldman sachs executive shawn canter as cfo further strengthens leadership
KULR Technology Group Inc (NYSE:KULR) announced it has strengthened its executive leadership team with the appointment of Shawn Canter as its new chie...
March 29, 2023, 9:23 am
U.k. regulator to refer broadcom deal for vmware for further review
The U.K. Competition and Markets Authority followed through on a threat made last week to refer the agreed acquisition by Broadcom AVGOof VMware VMW f...
March 29, 2023, 6:18 am
Should you buy viking therapeutics stock after it skyrocketed over 60%?
Viking Therapeutics announced promising results on Tuesday from a phase 1 study of obesity drug VX2735....
March 29, 2023, 5:54 am
Unity (unx) down on disappointing results from wet amd study
Unity's (UBX) phase II ENVISION study on UBX1325 fails to meet the non-inferiority threshold compared t...
March 28, 2023, 4:45 pm
Here's why viking therapeutics rose over 50% on obesity drug data
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive ...
March 28, 2023, 1:01 pm
Why is monopar therapeutics (mnpr) stock down 47% today?
Monopar Therapeutics (NASDAQ: MNPR ) stock is taking a beating on Tuesday after the company revealed lackluster clinical trial results. These results ...
March 28, 2023, 9:19 am
Allarity's stock falls after saying enrollment in two clinical trials is slow
Shares of Allarity Therapeutics Inc. ALLR, -4.51% plunged 17% in premarket trading on Tuesday after the company told investors that it's struggled to ...
March 28, 2023, 8:34 am
Viking's stock rallies as it announces trial for oral version of obesity drug
Shares of Viking Therapeutics Inc. VKTX, +3.05% soared about 45% in premarket trading on Tuesday after the company said it started a ...
March 28, 2023, 8:19 am
Intra-cellular's stock jumps on new data for depression drug
Shares of Intra-Cellular Therapies Inc. ITCI, +2.46% jumped about 15% in premarket trading on Tuesday after the company said its experimental treatmen...
March 28, 2023, 8:16 am
Revive therapeutics enrols first patient in psilocybin clinical study for methamphetamine use disorder
Revive Therapeutics Ltd (CSE:RVV, OTCQB:RVVTF) said it has enrolled the first patient in its phase I/II...
March 28, 2023, 7:47 am
Tiziana life sciences plans to accept us fda recommendations and start phase 2 study in q3 2023
Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it has received feedback based on the US Food and Drug Administration (FDA) Type C meeting minutes relate...
March 28, 2023, 7:31 am